Myriad Genetics Shares Are Trading Lower After the Company Announced That It Discontinued the Second Part of Its Study Due to the Disparities Between the GeneSight Group and Control Group.
Myriad Genetics Shares Are Trading Lower After the Company Announced That It Discontinued the Second Part of Its Study Due to the Disparities Between the GeneSight Group and Control Group.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated